Palomino Laboratories (PALX) Payables (2022 - 2025)

Palomino Laboratories (PALX) has 4 years of Payables data on file, last reported at $55687.0 in Q4 2025.

• For the quarter ending Q4 2025, Payables rose 765.92% year-over-year to $55687.0; the trailing twelve-month figure through Dec 2025 stood at $55687.0 (up 765.92% YoY), and the FY2025 full-year result was $55687.0, up 765.92% from the prior year.
• Payables declined to $55687.0 in Q4 2025, from $379702.0 in the prior quarter.
• In the past five years, Payables ranged from a high of $379702.0 in Q3 2025 to a low of $6431.0 in Q4 2024.
• A 4-year average of $129543.3 and a median of $79621.0 in 2023 frame the typical range for Payables.
• Across the five-year window, Payables tumbled 91.92% in 2024 and soared 765.92% in 2025, its largest moves.
• Tracing PALX's Payables over 4 years: stood at $12804.0 in 2022, then jumped by 521.84% to $79621.0 in 2023, then plunged by 91.92% to $6431.0 in 2024, then soared by 765.92% to $55687.0 in 2025.
• Business Quant data shows PALX's Payables at $55687.0 in Q4 2025, $379702.0 in Q3 2025, and $60781.0 in Q2 2025.